ID   POLZ D2781N
AC   CVCL_JH09
SY   Nalm-6-MSH+/TK+/-/REV3L D2781N
DR   JCRB; JCRB1489
DR   Wikidata; Q54947736
CC   Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11830; TK1.
CC   Sequence variation: REV3L p.Asp2781Asn; by homologous recombination.
CC   Sequence variation: Heterozygous for EGFR p.Arg1068Ter (c.3202C>T) (from parent cell line).
CC   Sequence variation: Heterozygous for NRAS p.Ala146Thr (c.436G>A) (from parent cell line).
CC   Sequence variation: Heterozygous for RARA p.Gln45Ter (c.133C>T) (from parent cell line).
CC   Transfected with: HGNC; 7235; MSH2 (exons 9 to 16).
CC   Derived from sampling site: Peripheral blood.
ST   Source(s): JCRB
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 12-03-20; Version: 5
//